ENPP3
Basic information
Region (hg38): 6:131628442-131747418
Previous symbols: [ "PDNP3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ENPP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 47 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 71 | 73 | ||||
Total | 0 | 0 | 118 | 6 | 2 |
Variants in ENPP3
This is a list of pathogenic ClinVar variants found in the ENPP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-131637410-C-T | not specified | Likely benign (Oct 25, 2023) | ||
6-131637451-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
6-131641480-T-C | not specified | Uncertain significance (Jun 09, 2022) | ||
6-131641516-A-T | not specified | Uncertain significance (Sep 27, 2024) | ||
6-131650057-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
6-131652607-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
6-131652863-A-T | not specified | Uncertain significance (Feb 07, 2023) | ||
6-131652887-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
6-131658328-A-T | not specified | Uncertain significance (Oct 29, 2021) | ||
6-131658331-T-C | not specified | Uncertain significance (Nov 28, 2024) | ||
6-131658400-T-A | not specified | Uncertain significance (May 12, 2024) | ||
6-131658418-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
6-131671268-A-G | not specified | Uncertain significance (Aug 20, 2024) | ||
6-131671285-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
6-131671317-C-A | not specified | Uncertain significance (Jul 09, 2024) | ||
6-131674172-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
6-131674181-A-G | not specified | Uncertain significance (Dec 11, 2023) | ||
6-131674207-G-A | not specified | Uncertain significance (May 21, 2024) | ||
6-131674272-T-A | not specified | Likely benign (Nov 17, 2022) | ||
6-131674272-T-G | not specified | Likely benign (Jan 26, 2022) | ||
6-131674285-T-C | Likely benign (Jun 23, 2018) | |||
6-131675099-A-G | not specified | Uncertain significance (Aug 14, 2023) | ||
6-131675155-G-T | not specified | Uncertain significance (Oct 30, 2024) | ||
6-131677878-T-C | not specified | Uncertain significance (Jul 10, 2023) | ||
6-131683076-T-C | not specified | Uncertain significance (Sep 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ENPP3 | protein_coding | protein_coding | ENST00000414305 | 25 | 118972 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.47e-23 | 0.0532 | 125073 | 1 | 672 | 125746 | 0.00268 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0744 | 463 | 468 | 0.990 | 0.0000229 | 5805 |
Missense in Polyphen | 175 | 192.54 | 0.90889 | 2439 | ||
Synonymous | -0.491 | 169 | 161 | 1.05 | 0.00000805 | 1557 |
Loss of Function | 1.40 | 41 | 51.9 | 0.790 | 0.00000260 | 647 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00482 | 0.00482 |
Ashkenazi Jewish | 0.000697 | 0.000695 |
East Asian | 0.00158 | 0.00152 |
Finnish | 0.00208 | 0.00208 |
European (Non-Finnish) | 0.00278 | 0.00277 |
Middle Eastern | 0.00158 | 0.00152 |
South Asian | 0.00504 | 0.00494 |
Other | 0.00261 | 0.00261 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolase that metabolizes extracellular nucleotides, including ATP, GTP, UTP and CTP (PubMed:29717535). Limits mast cell and basophil responses during inflammation and during the chronic phases of allergic responses by eliminating the extracellular ATP that functions as signaling molecule and activates basophils and mast cells and induces the release of inflammatory cytokines. Metabolizes extracellular ATP in the lumen of the small intestine, and thereby prevents ATP-induced apoptosis of intestinal plasmacytoid dendritic cells (By similarity). Has also alkaline phosphodiesterase activity (PubMed:11342463). {ECO:0000250|UniProtKB:Q6DYE8, ECO:0000269|PubMed:11342463, ECO:0000269|PubMed:29717535}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Nicotinate and nicotinamide metabolism - Homo sapiens (human);Starch and sucrose metabolism - Homo sapiens (human);Pantothenate and CoA biosynthesis - Homo sapiens (human);Riboflavin metabolism - Homo sapiens (human);Purine metabolism - Homo sapiens (human);IL-3 Signaling Pathway;Pathways in clear cell renal cell carcinoma;Pyrimidine metabolism;Vitamin B2 (riboflavin) metabolism;Vitamin B3 (nicotinate and nicotinamide) metabolism;Vitamin B5 - CoA biosynthesis from pantothenate;Nicotinate Nicotinamide metabolism;Pyrimidine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.423
Intolerance Scores
- loftool
- 0.935
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 75.68
Haploinsufficiency Scores
- pHI
- 0.130
- hipred
- N
- hipred_score
- 0.254
- ghis
- 0.379
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.599
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Enpp3
- Phenotype
- digestive/alimentary phenotype; immune system phenotype; respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;
Gene ontology
- Biological process
- basophil activation involved in immune response;pyrimidine nucleotide metabolic process;phosphate-containing compound metabolic process;receptor-mediated endocytosis;nucleoside triphosphate catabolic process;inorganic diphosphate transport;negative regulation of mast cell activation involved in immune response;ATP metabolic process;negative regulation of inflammatory response;negative regulation of mast cell proliferation;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- external side of plasma membrane;integral component of membrane;apical plasma membrane;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- nucleic acid binding;phosphodiesterase I activity;scavenger receptor activity;calcium ion binding;zinc ion binding;polysaccharide binding;NADH pyrophosphatase activity;nucleoside-triphosphate diphosphatase activity